WVE logo

Wave Life Sciences Ltd. (WVE)

Profile

Full Name

Wave Life Sciences Ltd.

Ticker

NASDAQ: WVE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Singapore

IPO

November 11, 2015

Indexes

Not included

Website

https://wavelifesciences.com

Employees

287

Key Details

Price

$7.16(-3.11%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$108.30M(-4.42% YoY)

Annual EPS

-$0.70(-29.63% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.16
    WVE price is $7.16

    30-Day Relative Volume

    1.07
    WVE 30-day relative volume is 1.07

    Price Performance

    Price Today change

    -3.11%
    WVE price is down -3.11% today

    Price YTD change

    -42.12%
    WVE price is down -42.12% since January 1st

    Price 1-year change

    +21.36%
    WVE price is up +21.36% year-on-year

    Price 3-year change

    +121.67%
    WVE price is up +121.67% over the past 3 years

    Price Range

    Price All-time high

    $56.00
    WVE price is currently -87.21% below its historical high of $56.00

    Price 3-year low

    $3.04
    WVE price is currently +135.53% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.14B
    WVE market capitalization is $1.14 billion

    Market cap 3-year change

    +306.32%
    WVE market capitalization is up +306.32% over the past 3 years

    Market cap All-time high

    $2.51B
    WVE market capitalization is currently -54.56% below its historical high of $2.51 billion

    Market cap sector rank

    73.36%
    WVE market capitalization is higher than 73.36% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +27.58%
    WVE shares outstanding is up +27.58% year-on-year

    Shares Outstanding 3-Year Change

    +83.3%
    WVE shares outstanding is up +83.3% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.48
    WVE beta is 1.48

    200-day SMA

    $9.37
    WVE price is currently -23.58% below its 200-day simple moving average

    50-day SMA

    $8.43
    WVE price is currently -15.07% below its 50-day simple moving average

    RSI

    31.22
    WVE 14-day relative strength index is 31.22

    Volume

    1.07
    WVE 30-day relative volume is 1.07

    ATR

    $0.61
    WVE average true range is $0.61

    10-day Historical Volatility

    89.68%
    WVE 10-day historical volatility is 89.68%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $108.30M
    WVE annual revenue is $108.30 million

    Revenue Analysts estimate

    $46.79M
    WVE annual revenue is currently +131.44% higher than the consensus analysts' forecast

    Revenue 1-year change

    -4.42%
    WVE annual revenue is down -4.42% year-on-year

    Revenue Sector rank

    68.86%
    WVE annual revenue is higher than 68.86% of companies in Healthcare sector

    EPS

    EPS

    -$0.70
    WVE annual earnings per share is -$0.70

    EPS Analysts estimate

    -$1.15
    WVE annual earnings per share is currently -38.91% lower than the consensus analysts' forecast

    EPS 1-year change

    -29.63%
    WVE annual earnings per share is down -29.63% year-on-year

    EPS Sector rank

    58.62%
    WVE annual earnings per share is higher than 58.62% of companies in Healthcare sector

    Profit

    Gross profit

    $99.64M
    WVE annual gross profit is $99.64 million

    Gross margin

    92.00%
    WVE annual gross profit margin is 92.00%

    Operating profit

    -$110.40M
    WVE annual operating income is -$110.40 million

    Operating margin

    -101.94%
    WVE annual operating profit margin is -101.94%

    Net income

    -$97.01M
    WVE annual net profit is -$97.01 million

    Net margin

    -89.57%
    WVE annual net profit margin is -89.57%

    Expenses

    Total expenses

    $218.71M
    WVE annual total expenses is $218.71 million

    Operating expenses

    $218.71M
    WVE annual total operating expenses is $218.71 million

    Cost of goods sold

    $8.66M
    WVE annual cost of goods sold is $8.66 million

    Selling, general & administrative expenses

    $59.02M
    WVE annual SGA is $59.02 million

    Depreciation and amortization

    $8.66M
    WVE annual depreciation & amortization is $8.66 million

    Interest expense

    $0.00
    WVE annual interest expense is $0.00

    Income tax

    $0.00
    WVE annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$110.40M
    WVE annual earnings before interest & taxes is -$110.40 million

    EBITDA

    -$101.74M
    WVE annual EBITDA is -$101.74 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $352.21M
    WVE annual total assets is $352.21 million

    Non current assets

    $31.81M
    WVE annual long term assets is $31.81 million

    Current assets

    $320.39M
    WVE annual total current assets is $320.39 million

    Cash and cash equivalents

    $302.08M
    WVE annual cash & cash equivalents is $302.08 million

    Accounts receivable

    $1.42M
    WVE annual accounts receivable is $1.42 million

    Inventory

    $0.00
    WVE annual inventory is $0.00

    Liabilities

    Total liabilities

    $134.82M
    WVE annual total liabilities is $134.82 million

    Long term liabilities

    $31.74M
    WVE annual total long term liabilities is $31.74 million

    Current liabilities

    $110.95M
    WVE annual total current liabilities is $110.95 million

    Accounts payable

    $16.26M
    WVE annual accounts payable is $16.26 million

    Debt

    Total debt

    $25.40M
    WVE annual total debt is $25.40 million

    Total debt 1-year change

    -20.9%
    WVE annual total debt is down -20.9% year-on-year

    Long term debt

    $17.77M
    WVE annual long term debt is $17.77 million

    Short term debt

    $7.64M
    WVE annual short term debt is $7.64 million

    Equity & Capital

    Shareholders equity

    $217.39M
    WVE annual stockholders equity is $217.39 million

    Book value

    $209.51M
    WVE annual book value is $209.51 million

    Retained earnings

    -$1.12B
    WVE annual retained earnings is -$1.12 billion

    Working capital

    $209.44M
    WVE annual working capital is $209.44 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$151.03M
    WVE annual cash flow from operations is -$151.03 million

    Cash from operations 1-year change

    -677.24%
    WVE annual cash flow from operations is down -677.24% year-on-year

    Cash from investing

    -$938.00K
    WVE annual cash flow from investing activities is -$938.00 thousand

    Cash from investing 1-year change

    +15.87%
    WVE annual cash flow from investing activities is up +15.87% year-on-year

    Cash from financing

    $253.89M
    WVE annual cash flow from financing activities is $253.89 million

    Cash from financing 1-year change

    +91.57%
    WVE annual cash flow from financing activities is up +91.57% year-on-year

    CAPEX

    CAPEX

    $938.00K
    WVE annual capital expenditures is $938.00 thousand

    CAPEX 1-year change

    -15.87%
    WVE annual capital expenditures is down -15.87% year-on-year

    Free Cash Flow

    Free cash flow

    -$151.96M
    WVE annual free cash flow is -$151.96 million

    Free cash flow 1-year change

    -639.63%
    WVE annual free cash flow is down -639.63% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    92.00%
    WVE annual gross profit margin is 92.00%

    Operating margin

    -101.94%
    WVE annual operating profit margin is -101.94%

    Net margin

    -89.57%
    WVE annual net profit margin is -89.57%

    ROA & ROE

    ROA

    -30.94%
    WVE annual return on assets is -30.94%

    ROE

    -73.24%
    WVE annual return on equity is -73.24%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    WVE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    WVE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    8.18
    WVE price to book ratio is 8.18

    PB ratio Sector rank

    86.1%
    WVE price to book ratio is higher than 86.1% of companies in Healthcare sector

    PS Ratio

    PS ratio

    12.13
    WVE price to sales ratio is 12.13

    PS ratio Sector rank

    75.31%
    WVE price to sales ratio is higher than 75.31% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $952.68M
    WVE enterprise value is $952.68 million

    Enterprise value Sector rank

    72.78%
    WVE enterprise value is higher than 72.78% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.07
    WVE EV/EBITDA is -7.07

    EV/EBITDA Sector rank

    18.08%
    WVE EV/EBITDA is higher than 18.08% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.89
    WVE annual current ratio is 2.89

    Quick ratio

    2.89
    WVE annual quick ratio is 2.89

    Leverage

    Debt to equity

    0.12
    WVE annual debt to equity ratio is 0.12

    Interest coverage ratio

    -
    WVE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    WVE piotroski f-score is 2

    Altman Z-Score

    0.60
    WVE altman z-score is 0.60

    Analyst ratings

    Recent major analysts updates

    Sep 4, 25 Wells Fargo
    Overweight
    Sep 3, 25 HC Wainwright & Co.
    Buy
    Aug 4, 25 Canaccord Genuity
    Buy
    Jul 31, 25 Wells Fargo
    Overweight
    Jul 28, 25 Oppenheimer
    Outperform
    Jul 16, 25 Citigroup
    Buy
    Jun 23, 25 Wedbush
    Outperform
    Apr 29, 25 Cantor Fitzgerald
    Overweight
    Mar 26, 25 HC Wainwright & Co.
    Buy
    Mar 5, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with WVE included

    Growing Shares Outstanding
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    NASDAQ Listed Companies
    • What is the ticker symbol for Wave Life Sciences Ltd.?
    • Does Wave Life Sciences Ltd. pay dividends?
    • What sector is Wave Life Sciences Ltd. in?
    • What industry is Wave Life Sciences Ltd. in?
    • What country is Wave Life Sciences Ltd. based in?
    • When did Wave Life Sciences Ltd. go public?
    • Is Wave Life Sciences Ltd. in the S&P 500?
    • Is Wave Life Sciences Ltd. in the NASDAQ 100?
    • Is Wave Life Sciences Ltd. in the Dow Jones?
    • When was Wave Life Sciences Ltd.'s last earnings report?
    • When does Wave Life Sciences Ltd. report earnings?

    What is the ticker symbol for Wave Life Sciences Ltd.?

    The ticker symbol for Wave Life Sciences Ltd. is NASDAQ:WVE

    Does Wave Life Sciences Ltd. pay dividends?

    No, Wave Life Sciences Ltd. does not pay dividends

    What sector is Wave Life Sciences Ltd. in?

    Wave Life Sciences Ltd. is in the Healthcare sector

    What industry is Wave Life Sciences Ltd. in?

    Wave Life Sciences Ltd. is in the Biotechnology industry

    What country is Wave Life Sciences Ltd. based in?

    Wave Life Sciences Ltd. is headquartered in Singapore

    When did Wave Life Sciences Ltd. go public?

    Wave Life Sciences Ltd.'s initial public offering (IPO) was on November 11, 2015

    Is Wave Life Sciences Ltd. in the S&P 500?

    No, Wave Life Sciences Ltd. is not included in the S&P 500 index

    Is Wave Life Sciences Ltd. in the NASDAQ 100?

    No, Wave Life Sciences Ltd. is not included in the NASDAQ 100 index

    Is Wave Life Sciences Ltd. in the Dow Jones?

    No, Wave Life Sciences Ltd. is not included in the Dow Jones index

    When was Wave Life Sciences Ltd.'s last earnings report?

    Wave Life Sciences Ltd.'s most recent earnings report was on July 30, 2025

    When does Wave Life Sciences Ltd. report earnings?

    The next expected earnings date for Wave Life Sciences Ltd. is November 10, 2025
    On this page